DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

Mesa’s business leaders will take a deep dive into how the Trump administration’s policies – such as hiking tariffs, freezing ...

Any time we try a healthy new way of eating, it’s easy for doubt to creep in. Is it really working? Is it worth it? Does it ...

Almost 2.4 million Americans wear continuous glucose monitors, or CGMs, to track their blood sugar—and not all of them have ...

Dexcom: This continuous glucose monitoring systems (CGM) developer introduced a proprietary GenAI platform, becoming the first CGM manufacturer to integrate GenAI into glucose biosensing technology.

The National Pet Care Fund (NPCF), a registered Canadian charity is pleased to provide a summary of its activities during the launch phase of its operations. The Charity was established to help reduce ...

Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical ...